Cadrenal Therapeutics, Inc.

New Filing
CIK: 0001937993·Biotechnology·DELAWARE·Filed: Jul 15, 2026
Total Offering

$8,843,849

Amount Sold

$8,843,849

Investors

1

First Sale

Jun 30, 2026

Offering Details

Type
Option to Acquire, Security to be Acquired
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2022
Non-Accredited Investors
No

Related Persons

NameRole
Quang X. Pham
John P. Sharp
James J. Ferguson
Jeffrey S. Cole
Lee Golden
John R. Murphy
Glynn Wilson

Company

Cadrenal Therapeutics, Inc.

822 A1A NORTH, SUITE 306

PONTE VEDRA, FL, 32082

(904) 300-0701

SEC Filing

0001213900-26-078373

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free